Pliant Therapeutics Total Current Liabilities

Pliant Therapeutics (PLRX) currently reports a total current liabilities of $16M as of June 2026. That compares with $21M in the prior-year period — down 19.9% year over year. Use the charts on this page to explore Pliant Therapeutics's total current liabilities history and peer comparisons.

Pliant Therapeutics's total current liabilities decreased from $21M to $16M — a 19.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pliant Therapeutics reported $16M in total current liabilities as of June 2026. That compares with $21M in the prior-year period — down 19.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pliant Therapeutics, and consider following PLRX for alerts when major investors trade the stock.

Pliant Therapeutics is classified in the Healthcare sector. On total current liabilities, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLRX with unrelated industries.